Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The serine/threonine kinase Akt is an upstream positive regulator of the mammalian target of rapamycin (mTOR). However, the mechanism by which Akt activates mTOR is not fully understood. The known pathway by which Akt activates mTOR is via direct phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2), which is a negative regulator of mTOR. Here we establish an additional pathway by which Akt inhibits TSC2 and activates mTOR. We provide for the first time genetic evidence that Akt regulates intracellular ATP level and demonstrate that Akt is a negative regulator of the AMP-activated protein kinase (AMPK), which is an activator of TSC2. We show that in Akt1/Akt2 DKO cells AMP/ATP ratio is markedly elevated with concomitant increase in AMPK activity, whereas in cells expressing activated Akt there is a dramatic decrease in AMP/ATP ratio and a decline in AMPK activity. Currently, the Akt-mediated phosphorylation of TSC2 and the inhibition of AMPK-mediated phosphorylation of TSC2 are viewed as two separate pathways, which activate mTOR. Our results demonstrate that Akt lies upstream of these two pathways and induces full inhibition of TSC2 and activation of mTOR both through direct phosphorylation and by inhibition of AMPK-mediated phosphorylation of TSC2. We propose that the activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT positively regulates mTOR (activator of PGC-1α) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1α) and GSK3b (regulator of PGC-1α turnover) [67, 70].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Self-citationTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
Research works printed but not linked: 3
- Sapkota, 2002, Biochem. J., 362, 481, 10.1042/bj3620481 · doi:10.1042/bj3620481
- Sekulic, 2000, Cancer Res., 60, 3504
- Parsons, 2003, Methods Mol. Biol., 222, 147
Cited by
Items 401–500 of 553
Kim, T. H., Eom, J. S., Lee, C. G., Yang, Y. M., Lee, Y. S., & Kim, S. G. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12057 · Cited by 13
Jung, Y., Lee, K., Kim, M.-K., Jung, G., Seo, Y.-J., Kim, H., Cho, H., Lee, K., Park, K., & Lee, I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.124 · Cited by 12
Dubon, M. J., Byeon, Y., & Park, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4453 · Cited by 12
Kútna, V., O'Leary, V. B., Newman, E., Hoschl, C., & Ovsepian, S. V. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-01000-7 · Cited by 11
Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy
Daher, A. A., Alkhansa, S., Azar, W. S., Rafeh, R. W., Ghadieh, H. E., & Eid, A. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0217 · Cited by 13
Behrouz, H., Esfandyari‐Manesh, M., Khoeeniha, M. K., Amini, M., Varnamkhasti, B. S., Atyabi, F., & Dinarvand, R. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12750 · Cited by 12
PIM3-AMPK-HDAC4/5 axis restricts MuERVL-marked 2-cell-like state in embryonic stem cells
Zhao, X. J., Shen, J., Zhao, X., Zhang, M., Feng, X. M., Zhang, W., & Lu, X. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.08.009 · Cited by 11
Roopashree, P. G., Shetty, S. S., Shetty, V. V., Suhasini, P. C., & Kumari, S. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30571 · Cited by 13
Jiang, A.-G., Yu, H., & Jian-an, H. (2014) · Oncology Letters · doi:10.3892/ol.2014.2167 · Cited by 11
Tian, Z., Ma, X., Deng, D., Cui, Y., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06712 · Cited by 11
Srivastava, S., Bagang, N., Yadav, S., Rajput, S., Sharma, D., Dahiya, A., Bhardwaj, L., Deshmukh, K., Joshi, J. C., & Singh, G. (2021) · Inflammation Research · doi:10.1007/s00011-021-01477-8 · Cited by 13
Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis
Maitiabula, G., Tian, F., Wang, P., Zhang, L., Gao, X., Wan, S., Sun, H., Yang, J., Zhang, Y., Gao, T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.008 · Cited by 12
Thermal Injury Activates the eEF2K‐Dependent eEF2 Pathway in Pediatric Patients
Song, J., Finnerty, C. C., Herndon, D. N., Kraft, R., Boehning, D. F., Brooks, N. C., Tompkins, R. G., & Jeschke, M. G. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111422234 · Cited by 11
Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?
Oettinger, D., & Yamamoto, A. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169219 · Cited by 11
Huang, J., Zhao, L., Gong, C., Wang, Y., Qu, Y., Ji, C., & Yang, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5386050 · Cited by 10
Fragiadaki, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166358 · Cited by 11
Zhuang, L., Ma, W., & Jiao, J. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s435624 · Cited by 10
Dalton (2010) · International Journal of Oncology · doi:10.3892/ijo_00000754 · Cited by 10
Tawila, A. M., Sun, S., Kim, M. J., Omar, A. M., Dibwe, D. F., & Awale, S. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000495 · Cited by 10
Potential Role of Mammalian Target of Rapamycin Inhibitors in Breast Cancer Therapy
Meric‐Bernstam, F., & Esteva, F. J. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.041 · Cited by 10
Yi, Q., Xi, Y., Li, J., Wu, Z., Ma, Y., Jiang, Y., Yang, D., & Huang, S. (2024) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2024.105194 · Cited by 9
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2020) · Genetics · doi:10.1093/genetics/iyaa010 · Cited by 9
Freitas, L. A. B., Sousa, C., Lima, B. S., Duarte, D., Gomes, P. A. T. D. M., Ramos, C. G. C., da Costa, V. D. C. M., Pitta, M. G. D. R., Rêgo, M. J. B. D. M., de Simone, C. A., et al. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110954 · Cited by 10
AKT as Locus of Cancer Phenotype
Radisavljevic, Z. M. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24947 · Cited by 9
AMPK signaling: A targetable tumor suppressor pathway?
Schneider, A., & Gartenhaus, R. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13921 · Cited by 9
Physiology of cellular demise: Apoptosis, necrosis, and autophagy
Kaur, D., & Deshmukh, R. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815762-6.00002-0 · Cited by 14
DMH1 Increases Glucose Metabolism through Activating Akt in L6 Rat Skeletal Muscle Cells
Xie, X., Xu, X., Li, N., Zhang, Y.-H., Zhao, Y., Ma, C.-Y., & Dong, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107776 · Cited by 9
Urinary Metabolomic Profiling of Patients with Glioblastoma Multiforme
Tandle, A. T. (2013) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.s6-003 · Cited by 12
Zhang, T., Liu, J., Zheng, X., Zhang, B., & Xia, C. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3285 · Cited by 9
Cell signaling and cancer‐possible targets for therapy
Wenner, C. E. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22021 · Cited by 9
Li, Y., Feng, Y., Yang, Z., Zhou, Z., Jiang, D., & Luo, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1206462 · Cited by 10
In silico and in vitro approaches to evaluate the bioactivity of Cassia auriculata L extracts
Anitha, R., Subashini, R., & Kumar, P. S. (2020) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2019.0364 · Cited by 8
AICAR enhances insulin signaling via downregulation of miR-29
Liu, J., Ye, C., Liu, W., Zhao, W., Zhang, Y., Zhang, H., & Ying, H. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0159 · Cited by 8
Novel Stem Cell Strategies with mTOR
Maiese, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00020-7 · Cited by 11
Wehbe, Z., Alatibi, K. I., Jellusova, J., Spiekerkoetter, U., & Tucci, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.08.001 · Cited by 8
Nature’s Timepiece—Molecular Coordination of Metabolism and Its Impact on Aging
Bednářová, A., Kodrík, D., & Krishnan, N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023026 · Cited by 7
Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia
Balakrishnan, K., & Gandhi, V. V. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.668526 · Cited by 8
Jung, E.-J., Lee, W.-J., Bae, J.-W., & Kwon, W. (2024) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2024.104565 · Cited by 6
Su, M., Hsieh, S.-Y. S., Lee, Y.-R., Chang, M., Yuan, T. T., & Chang, J. (2010) · Cell Biochemistry and Function · doi:10.1002/cbf.1685 · Cited by 6
Ullah, F., Bhattarai, D., Cheng, Z., Liang, X., Deng, T., Rehman, Z. U., Talpur, H. S., Worku, T., Dad, R., Safdar, M., et al. (2018) · BioMed Research International · doi:10.1155/2018/1463732 · Cited by 6
Yu, C., Fu, J., Guo, L., Yu, M., & Yu, D. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5436979 · Cited by 8
Luperchio, A. M., & Salamango, D. J. (2025) · Cells · doi:10.3390/cells14050342 · Cited by 5
Ограничение питательных веществ как подход к комбинированной терапии опухолей
Senichkin, V. V., Kopeina, G. S., Zamaraev, A. V., Lavrik, I. N., & Животовский, Б. Д. (2016) · Molecular Biology · doi:10.7868/s0026898416030101 · Cited by 6
Nutrient restriction in combinatory therapy of tumors
Senichkin, V. V., Kopeina, G. S., Zamaraev, A. V., Lavrik, I. N., & Zhivotovsky, B. (2016) · Molecular Biology · doi:10.1134/s0026893316030109 · Cited by 5
Interplay Between Metabolic Sensors and Immune Cell Signaling
Chauhan, P. S., Sarkar, A., & Saha, B. (2018) · Experientia supplementum · doi:10.1007/978-3-319-74932-7_3 · Cited by 7
Jahani, Z., & Davoodi, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.052 · Cited by 5
Forskolin attenuates the action of insulin on the Akt–mTOR pathway in human skeletal muscle
Richmond, S. R., Touchberry, C. D., & Gallagher, P. M. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-096 · Cited by 5
Dongye, C., Chen, X., Zhao, Y., Li, H., Abdallah, M. F., Li, T., & Chen, X. (2025) · Environment & Health · doi:10.1021/envhealth.4c00250 · Cited by 4
Transglutaminase 2 regulates innate immunity: mechanisms and therapeutic implications
D’Eletto, M., Occhigrossi, L., Colasuonno, F., Bellanca, V., Sano, F. D., Montesano, C., Ciccosanti, F., Shi, Y. Q., Piacentini, M., & Rossin, F. (2026) · OncoImmunology · doi:10.1080/2162402x.2026.2665505 · Cited by 4
AMP-Activated Protein Kinase: A Metabolic Stress Sensor in the Heart
Pelosse, M., Tokarska-Schlattner, M., & Schlattner, U. (2015) · Springer eBooks · doi:10.1007/978-3-319-15263-9_10 · Cited by 6
Vallianou, N. G., Evangelopoulos, A. A., Geladari, E. V., & Kazazis, C. E. (2015) · Hospital chronicles/Hospital Chronicles · doi:10.2015/hc.v10i3.691 · Cited by 4
Montesinos‐Cruz, V., Parra-Forero, L. Y., & Contreras, A. D. C. G. (2023) · Frontiers in Animal Science · doi:10.3389/fanim.2023.1275290 · Cited by 4
Immunosenescence and Cancer Immunotherapy at Old Age: Basics
Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-44870-1_77-1 · Cited by 4
Heydemann, A., González-Vega, M., Berhanu, T. K., Mull, A. J., Sharma, R., & Holley-Cuthrell, J. (2016) · PubMed · Cited by 4
Immunosenescence and Cancer Immunotherapy at Old Age: Basics
Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_77 · Cited by 5
Gao, J.-Y., Lei, B., He, H., Xi, D., Wu, Q., Wang, X., Li, N., Tian, Z., Zhu, Q., & Yu, Y. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-024-00480-4 · Cited by 3
BPA-induced disruption of muscle development and larval metamorphosis in the mussel Mytilus coruscus
Huang, S., Wang, Y., Ni, J.-Y., & Li, Y.-F. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107368 · Cited by 4
Park, S. Y., & Park, O. J. (2010) · Food Science and Biotechnology · doi:10.1007/s10068-010-0218-4 · Cited by 3
Caetano-Silva, S. P., Simbi, B. H., Marr, N., Hibbert, A. P., Allen, S., & Pitsillides, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413220 · Cited by 3
Inferring Intracellular Signal Transduction Circuitry from Molecular Perturbation Experiments
Wynn, M. L., Egbert, M. E., Consul, N., Chang, J., Wu, Z.-F., Meravjer, S. D., & Schnell, S. D. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0270-9 · Cited by 3
So, L. Y., & Miller, J. E. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112955 · Cited by 4
McLoughlin, T. J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01241.2009 · Cited by 3
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/606699 · Cited by 3
AMPK—friend or foe for targeted therapy?
Choudhury, Y., Salt, I. P., & Leung, H. Y. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1022066 · Cited by 2
Therapeutic strategies for targeting cancer stem cells
Alkon, N., Ivanova, A. E., Frolova, E. I., & Chumakov, S. P. (2018) · Genes and Cells · doi:10.23868/201808016 · Cited by 2
Targeting the Tumor Microenvironment to Overcome Resistance to Therapy
Qorri, B., & Szewczuk, M. R. (2019) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-030-21477-7_2 · Cited by 2
Wang, J., Guo, Q., Miao, Y., & Shi, H.-Z. (2020) · Aquaculture Research · doi:10.1111/are.15038 · Cited by 2
Reed, C. H., Tystahl, A. C., Eo, H., Buhr, T. J., Bauer, E. E., Lee, J. H., Clark, P., & Valentine, R. J. (2024) · Biomolecules · doi:10.3390/biom14050527 · Cited by 3
Buyan, M. I., Pevzner, I. B., Buyan, A., Zorova, L. D., Zorov, D. B., Andrianova, N. V., & Plotnikov, E. Y. (2025) · IUBMB Life · doi:10.1002/iub.70044 · Cited by 2
Wu, C., Liu, L., Huo, J., Li, D., Yuan, Y., Feng, Y. U. A. N., & Miao, Y. (2013) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1305-33 · Cited by 2
Neurological manifestations of Proteus syndrome – review of the literature.
Ogrodnik, M., Sadowski, K., & Jóźwiak, S. (2015) · Child Neurology · doi:10.20966/chn.2015.49.353 · Cited by 2
Dinh, T., Onea, A. S., & Jazirehi, A. R. (2017) · Europe PMC (PubMed Central) · Cited by 2
The physiological modulation by intracellular kinases of hippocampal γ-oscillation in vitro
Wang, J., Gao, X., Wang, Y., Wang, M., Ge, C., Liu, Z., Xie, X., Chen, Z., Song, J., & Lu, C. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00199.2019 · Cited by 2
Carotti, V., van Megen, W. H., Rigalli, J. P., Barros, E., Sommers, V., Rutten, L., Sommerdijk, N. A. J. M., Peters, D. J. M., van der Wijst, J., & Hoenderop, J. G. J. (2023) · The FASEB Journal · doi:10.1096/fj.202300490r · Cited by 3
Androgens and the Lipogenic Switch in Prostate Cancer
Swinnen, J. V., Brusselmans, K., Heemers, H. V., & Verhoeven, G. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_31 · Cited by 1
Shanavas, S., Sen, U., Sudheer Shenoy, P., & Bose, B. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_96 · Cited by 1
Kalafut, K. C., Cormerais, Y., Cissé, M. Y., Lapp, S. C., Inouye, K., Hotamışlıgil, G. S., & Manning, B. D. (2026) · Nature Communications · doi:10.1038/s41467-026-77216-6 · Cited by 2
The role of mTORC2 in the in vitro neurotoxicity of Parkinsonian mimetics 6-OHDA and MPP+
Jeremić, M., Jovanović-Tucović, M., Martinović, T., Kravić-Stevović, T., Stevanovic, D., Blagojević, S., Marković, I., & Trajković, V. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103497 · Cited by 1
mTORC1: A Signaling Integration Node Involved in Cell Growth
Kubica, N., & Blenis, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_1 · Cited by 1
Cellular Signaling Molecules Associated with Peptidoglycan-Induced CCL3 Up-Regulation
Kim, K.-S., Rhim, B.-Y., Eo, S. K., & Kim, K.-H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.3.302 · Cited by 1
Stratifying Cancer Therapies by Molecular Interactions and Imaging
Galazi, M., Weitsman, G. E., Monypenny, J., Coban, O., Milewicz, H., Gómez, V., Ciccarelli, F. D., & Ng, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-53661-3_15 · Cited by 1
Shanavas, S., Sen, U., Sudheer Shenoy, P., & Bose, B. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_96-1 · Cited by 1
Alghamdi, A., & Alissa, M. (2025) · Folia Biologica · doi:10.14712/fb2025071010008 · Cited by 1
TWIST1-overexpression induces glycolytic reprogramming and ATP production in 293T cells
Pehlivanoğlu, S., & Kont, K. A. (2020) · Eastern Journal Of Medicine · doi:10.5505/ejm.2020.63496 · Cited by 1
Molecular Mechanisms of AMPK- and Akt- Dependent Survival of Glucose-Starved Cardiac Myocytes
Chopra, I. (2012) · Cited by 1
Oxidative stress in Huntington's disease knock-in striatal cells
Ribeiro, M. J. D. C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
The role of the integrin β3 adhesome in angiogenesis
Atkinson, S. J. (2018) · UEA Digital Repository (University of East Anglia) · Cited by 1
La régulation du métabolisme du glucose par la protéine tyrosine phosphatase SHP-1
Bergeron, S. (2007) · Corpus Université Laval (Université Laval) · Cited by 1
Biosenseurs reposant sur l'AMPK et le FRET pour l'analyse du métabolisme énergétique : AMPFret
Pelosse, M. (2015) · theses.fr (ABES) · doi:10.70675/5e286e5cz52a5z4b90z890ez6ee25b5438db
The Bca2 And Ampk Paradigm: Unraveling The Cancer Connection
Ventro, D. (2013) · Human Biology
Targeting the mTOR Pathway for Tumor Therapeutics
Chen, W. (2009) · Wiley eBooks · doi:10.1002/9780470538951.ch22
Intracellular Signal Transduction Cascades
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch5
Molecular Mechanisms through Which Peptidoglycan Induces IL-1β Expression in Monocytic Cells
Seo, H.-C., Kim, S., Lee, S.-A., Rhim, B.-Y., & Kim, K. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.12.1637
The Role of NPM-ALK Signaling in Tumor Cell Metabolism.
McDonnell, S. (2013) · Deep Blue (University of Michigan) · Cited by 1
Role of C-Kit Receptor Tyrosine Kinase on INS-1 Cell VEGF-A Expression in Vitro
Popell, A. (2014) · Scholarship@Western (Western University)
Beta Actin Antibody Review and FAQs
Johnson, M. (2013) · Materials and Methods · doi:10.13070/mm.en.3.179
The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Koropouli, E., Manolopoulos, L., Pandha, H., & Syrigos, K. (2009) · Current Enzyme Inhibition · doi:10.2174/157340809787314274
Park, C.-S., Kim, J.-H., Oh, Y.-K., Kim, K. H., Choi, C.-W., Cho, E.-S., Jeong, Y. D., & Park, S.-K. (2012) · Journal of Animal Science and Technology · doi:10.5187/jast.2012.54.5.369
NMDA Antagonism in the treatment of Major Depressive Disorder
Chalikiopoulos, A. P. A. (2013) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Hahn-Windgassen, A., Nogueira, V., Chen, C.-C., Skeen, J. E., Sonenberg, N., & Hay, N.
- Affiliations
- University of Illinois Chicago (US)
- McGill University (CA)
- Corresponding author
- Hay, Nissim
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 37
- Pages
- 32081-32089
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2170704593
- Cited by
- 539
- References
- 50
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 17 · 2022: 24 · 2021: 33 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 26 · 2015: 38 · 2014: 25 · 2013: 42 · 2012: 35
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5504 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- National Institute on Aging (R01AG016927, AG016927)
- National Cancer Institute (CA090764, R01CA090764)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007739)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- Akt, mTOR, AMPK, TSC2, AMP/ATP ratio, TSC2 phosphorylation, energy sensing
- MeSH terms
- Tuberous Sclerosis Complex 2 Protein, Adenine, Adenosine Triphosphate, Adenylate Kinase, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Activation, Gene Expression Regulation, Humans, Models, Biological, Phosphorylation, Plasmids, Protein Kinases, Proto-Oncogene Proteins, Repressor Proteins, Retroviridae, RNA, Messenger, Time Factors, Transfection, Protein Biosynthesis, Immunoblotting, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Tumor Suppressor Proteins, Immunoprecipitation, Proto-Oncogene Proteins c-akt, Mice, Rats, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.